Skip to main content
OpenTrials

Clinical trial condition

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

Explore clinical trials studying Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

19 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 trial results

Recruiting

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

NCT06203600

Conditions
Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +14 more
Locations
  • Baptist Health Medical Center - Little Rock Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 374 locations
View Trial Details
Recruiting

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

NCT05677490

Conditions
Adenocarcinoma Of Esophagus, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 794 locations
View Trial Details
Completed

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Melanoma, +85 more
Locations
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
  • Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
  • Island Urology Honolulu, Hawaii, United States
View all 144 locations
View Trial Details
Completed

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

NCT03918499

Conditions
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States
View Trial Details

Related conditions